Psychiatric Drug Withdrawal Symptoms

What happens when you stop, what's causing it, and what might actually help — from the research and from the people going through it.

guythetaperman.com • April 2026 • All claims sourced

⚠ Not medical advice. This page summarises peer-reviewed research and real-world peer experiences. It does not replace professional guidance. Never stop or change psychiatric medication without medical support. If you are in crisis contact Lifeline (13 11 14 in Australia) or your local emergency services.

Key: 📖 = From peer-reviewed research Forum-reported = Reported by peer communities (SurvivingAntidepressants, BenzoBuddies, Reddit withdrawal subs, RxISK) ⚠ = Known to worsen symptoms in some people

The Big Picture

Almost every class of psychiatric drug can produce withdrawal symptoms when reduced or stopped. The medical establishment argued for decades that this was rare or mild. The data tells a different story.

How Common Is Withdrawal? The Numbers Battle CONTESTED

▼

The most comprehensive meta-analysis to date (Henssler et al., Lancet Psychiatry, 2024) analysed 79 studies involving 21,000+ participants and estimated that roughly 15% of patients (1 in 6–7) experience withdrawal symptoms directly attributable to stopping antidepressants, with about 3% (1 in 35) experiencing severe symptoms. SRC

This was challenged by Moncrieff et al. (2025) and by Read & Davies (2024 reply), who pointed out that the Henssler review relied heavily on short-duration drug-company trials (many under 12 weeks of treatment), where only 29% used structured assessment tools. When structured tools were used, incidence was significantly higher (40% vs 27%). The earlier Davies & Read (2019) review found approximately 56% experience withdrawal, with ~46% rating it severe. SRC

Plain English: The true number probably sits somewhere between these estimates. The 15% figure comes from controlled trial data (short-term use, many company-funded). The 56% comes from real-world surveys of people who actually used antidepressants for years, which is how most people use them. The typical antidepressant user takes these drugs for several years — not 12 weeks.

Two Types of Withdrawal: Acute vs Protracted KEY CONCEPT

▼

Acute withdrawal presents with qualitatively new symptoms unrelated to the original condition. It emerges rapidly (days to weeks) after dose reduction or cessation and typically lasts 1–6 weeks. A subtype is rebound disorder, where the original symptoms return but at greater intensity. SRC

Protracted / Post-Acute Withdrawal Syndrome (PAWS) includes both new symptoms and original symptoms with greater intensity. It can appear days, weeks, or even months after stopping and last from months to years. It is frequently misdiagnosed as relapse or a new psychiatric condition. The etiology is largely unknown, but proposals include neural damage analogous to tardive dyskinesia and irreversible pharmacodynamic adaptations. SRC

Key problem: Reinstatement of the drug often does not resolve PAWS. This has led researchers to propose it could be caused by neural damage rather than simple receptor adaptation. Since reinstatement failure is common, PAWS cannot simply be "the original illness returning." SRC

The Language Battle: "Discontinuation" vs "Withdrawal" POLITICS

▼

The pharmaceutical industry promoted the term "discontinuation syndrome" specifically to avoid associating antidepressants with dependence and withdrawal. Researchers including Fava, Cosci, Moncrieff, Read, and Davies have argued this terminology is misleading and potentially harmful, as it causes clinicians to dismiss or misdiagnose genuine withdrawal as relapse.

The Maudsley Deprescribing Guidelines (Horowitz & Taylor, 2024) explicitly use the term "withdrawal" for antidepressants, benzos, gabapentinoids, and Z-drugs — a significant shift from mainstream psychiatry. SRC

The Math of Tapering & How to Manage It

Why cutting your dose by the same amount every month eventually hits a wall, and how to stay in control using hyperbolic tapering.

Why Linear Tapering Fails (The Hyperbolic Curve) KEY CONCEPT

▼

Psychiatric drugs don't affect your brain in a straight line. They follow a hyperbolic curve. This means the first few milligrams of a drug block a massive percentage of your receptors, while adding more drug later blocks very few extra.

The Trap: If you are on 20mg of a drug and drop to 10mg, you might only free up 10% of your brain's receptors. But when you drop from 2mg to 0mg, you might strip away 40% of the receptor blockade all at once. This is why so many people do fine at the beginning of a taper but "hit a wall" at the lower doses.

The Solution: Exponential (Hyperbolic) Tapering. Instead of dropping by fixed amounts (e.g., 2mg every month), you drop by a percentage of your current, previous dose. As your dose gets smaller, your cuts get smaller. This ensures your brain experiences an even rate of change.

GTT (Guy The Taperman) App: Doing the Math TOOL

▼

The problem with exponential micro-tapering is the math. Calculating exact daily or weekly milligram reductions based on shifting percentages is tedious, especially when dealing with withdrawal-induced cognitive fog.

GTT (Guy The Taperman) is a custom-built desktop application (available for Windows and Mac) designed specifically to solve this problem. It allows you to:

1Calculate precise reductions: Input your starting dose and desired reduction rate (e.g., 5% every 14 days), and GTT handles the complex exponential math instantly.

2Document your taper: Visually track your schedule and past cuts, so you never lose your place.

3Stay in control: If symptoms flare up, you can pause or adjust the reduction rate. The app recalculates the rest of your taper automatically.

Learn more about the GTT App here →

SSRIs — Selective Serotonin Reuptake Inhibitors

Fluoxetine (Prozac), Sertraline (Zoloft), Paroxetine (Paxil/Seroxat), Citalopram (Celexa), Escitalopram (Lexapro), Fluvoxamine (Luvox)

Withdrawal Symptoms COMMON

▼

Category	Symptoms	Typical Onset
Neurological	"Brain zaps" (electric shock sensations), dizziness, vertigo, paraesthesia (pins & needles), tremor, tinnitus	1–3 days
Psychological	Anxiety (often worse than pre-drug), irritability, emotional lability, crying spells, depersonalisation, derealization, rage, intrusive thoughts, akathisia	2–7 days
Physical	Nausea, vomiting, diarrhoea, headache, sweating, flu-like symptoms, fatigue, insomnia, vivid/disturbing dreams	1–4 days
Rare but serious	Suicidal ideation, psychosis (rare), mania, severe akathisia, POTS (postural orthostatic tachycardia)	Variable

SRC

HIGHEST ⬆Paroxetine (half-life ~21h, potent, also anticholinergic)

HIGHFluvoxamine, Citalopram, Escitalopram, Sertraline

LOWER ⬇Fluoxetine (half-life 4–6 days; active metabolite up to 16 days — self-tapers)

Symptom-by-Symptom: What Helps & What Hurts DETAILED

▼

Symptom	Proposed Cause	What Helps 📖	What Helps Forums	⚠ Can Worsen
Brain zaps	Serotonin receptor disruption; possibly noradrenergic withdrawal; neural misfiring in eye-movement circuits	Slower taper (Maudsley); time; some clinicians use short course of fluoxetine ("Prozac bridge") due to long half-life	Omega-3 fish oil (high EPA); magnesium glycinate; moving eyes slowly; avoiding sudden head movements	Caffeine (↑CNS excitability); alcohol; stress/sleep deprivation; 5-HTP while still on SSRI (serotonin syndrome risk)
Anxiety & Rapid Heart Rate	Acute hyposerotonergic state; GABA system disruption; HPA axis dysregulation	Slow taper; CBT; exercise (serotonin/endorphin boost); Propranolol (taken PRN/intermittently to block physical adrenaline without causing dependence)	Magnesium glycinate; L-theanine; chamomile tea; cold water on wrists/face (vagal activation); deep breathing; valerian root	Caffeine; cannabis; 5-HTP too early; Sensitised CNS: any new supplement can paradoxically increase anxiety — start micro-doses. Daily beta-blocker use builds dependence.
Insomnia & Nightmares	Serotonin regulates sleep-wake cycles; disrupted melatonin synthesis; histaminergic rebound	Sleep hygiene; melatonin (low dose 0.5–1mg); Prazosin (Minipress) PRN for severe trauma-like nightmares (blocks norepinephrine)	Magnesium glycinate before bed; tart cherry juice (natural melatonin); glycine powder; Epsom salt baths; blue-light blocking glasses; L-theanine	Screen use before bed; alcohol; antihistamines like diphenhydramine (rebound insomnia, anticholinergic load); Daily Prazosin use creates rebound hypertension risk.
GI symptoms (nausea, diarrhoea)	95% of body's serotonin is in the gut; SSRI withdrawal disrupts enteric serotonin signalling	Slower taper; ginger (evidence for nausea generally); bland diet	Ginger capsules/tea; peppermint tea; probiotics; small frequent meals; BRAT diet; bone broth	Spicy/fatty foods; large meals; MCAS patients: high-histamine foods can massively worsen GI symptoms
Akathisia (inner restlessness, can't sit still)	Dopaminergic disruption secondary to serotonin withdrawal; possibly direct effect on D2 receptors	Reinstatement or slower taper; Propranolol (first-line off-label treatment for akathisia); benzodiazepines (creates new dependency risk)	Walking/pacing; magnesium; weighted blankets; iron supplementation; cold water immersion	This is the most dangerous withdrawal symptom — linked to suicidal ideation. Caffeine worsens it. Antipsychotics can worsen it.

What Causes SSRI Withdrawal? MECHANISM

▼

Hypothesised Mechanism (not fully proven)

1Serotonin reuptake blocked: SSRIs block the serotonin transporter (SERT), increasing synaptic serotonin availability.

2Brain adapts (downregulation): Over weeks/months, the brain reduces serotonin receptor density (particularly post-synaptic 5-HT1A receptors) and may reduce its own serotonin production. This is neuroadaptation.

3Drug removed: When the SSRI is stopped, reuptake resumes normally — but the brain now has fewer receptors and possibly lower baseline serotonin production. This creates an acute hyposerotonergic state.

4Cascade effects: The serotonin deficit cascades into other neurotransmitter systems — dopamine, norepinephrine, GABA, and acetylcholine are all affected. This explains the extraordinary diversity of withdrawal symptoms.

SRC

Duration & Timeline VARIABLE

▼

Acute symptoms typically begin within 2–4 days of stopping (or reducing) and last 1–6 weeks for most people. One meta-analysis of online reports found SSRI withdrawal symptoms averaged 90.5 weeks in duration — though this self-selected sample likely skews toward more severe cases. SRC

Protracted withdrawal can last months to years. In the SurvivingAntidepressants.org community, founder Adele Framer (writing as Altostrata) documented communicating with over 10,000 individuals; many reported symptoms persisting for years. SRC

Delayed onset: Some people experience withdrawal weeks or months after their last dose — particularly with fluoxetine (due to its long half-life) or after very slow tapers. This often leads to misdiagnosis as "relapse." SRC

SNRIs — Serotonin-Norepinephrine Reuptake Inhibitors

Venlafaxine (Effexor), Desvenlafaxine (Pristiq), Duloxetine (Cymbalta)

Symptoms & Why SNRIs Are Worse NOTORIOUS

▼

SNRIs produce all the same symptoms as SSRIs (brain zaps, dizziness, nausea, anxiety, insomnia, etc.) but typically with greater intensity. Venlafaxine and desvenlafaxine are consistently ranked among the hardest psychiatric drugs to discontinue. SRC

Why worse? SNRIs affect two neurotransmitter systems (serotonin + norepinephrine), meaning the brain must readjust on two fronts simultaneously. Norepinephrine is critical for regulating alertness and arousal, which may explain why brain zaps and sensory disturbances are disproportionately common with SNRIs. Venlafaxine in particular has a very short half-life (~5 hours), meaning plasma levels crash rapidly after a missed dose.

SNRI-Specific Mechanism

1Serotonin + norepinephrine reuptake both blocked → dual neuroadaptation occurs

2On stopping: acute hyposerotonergic state PLUS adrenergic withdrawal

3Adrenergic withdrawal specifically linked to brain zaps — one PMC case report (2025) described brain zaps as "likely linked to adrenergic withdrawal," explaining their higher frequency with SNRIs vs SSRIs

SRC

Atypical Antidepressants (NaSSA & SARI)

Mirtazapine (Remeron) and Trazodone (Desyrel) behave very differently from SSRIs, making their withdrawal patterns uniquely challenging.

Mirtazapine: The Inverse Tapering Paradox WEIRD

▼

Mirtazapine is notorious for having a completely counter-intuitive tapering profile. Unlike most drugs where lowering the dose reduces side effects, lowering Mirtazapine often makes you more sedated.

The Mechanism Paradox

1Low Doses (≤15mg): Mirtazapine has an exceptionally high affinity for histamine H1 receptors. At low doses, it acts almost entirely as a massive, heavily sedating antihistamine.

2High Doses (30mg+): As the dose increases, it begins blocking alpha-2 adrenergic receptors. This increases activating neurotransmitters (norepinephrine), which counteracts and masks the sleepiness.

3The Taper Trap: When you taper down from a high dose, you lose the activating adrenaline first, but keep the heavy antihistamine sedation.

The Tail End: Because of this inverse curve, getting through the final low-dose stages of a Mirtazapine taper (under 7.5mg) can cause severe, debilitating grogginess, brain fog, and hypersomnia that catches many people off guard.

Trazodone: The Sleep Aid Trap SECONDARY DEPENDENCY

▼

Trazodone is a SARI (Serotonin Antagonist and Reuptake Inhibitor). Doctors frequently prescribe it off-label at low doses (50-100mg) specifically to treat the insomnia caused by withdrawing from other drugs like SSRIs or Benzos.

The Problem: You are simply swapping one dependency for another. Trazodone is a powerful psychiatric drug that blocks 5-HT2A, SERT, Alpha-1, and H1 receptors. When the time comes to stop the Trazodone, patients are hit with a brand new serotonergic and histaminergic withdrawal syndrome. This is the definition of polypharmacy trapping.

TCAs & MAOIs — The Older Antidepressants

Tricyclics: Amitriptyline, Imipramine, Clomipramine, Nortriptyline, Doxepin. MAOIs: Phenelzine, Tranylcypromine.

TCA Withdrawal Symptoms MULTI-SYSTEM

▼

TCAs affect serotonin, norepinephrine, histamine, acetylcholine, and adrenergic receptors — meaning withdrawal can involve all of these systems. The result is a particularly diverse symptom profile:

System	Symptoms	Mechanism
Cholinergic rebound	Nausea, vomiting, diarrhoea, abdominal cramps, excessive sweating, headache, myalgia	TCAs block acetylcholine receptors → when stopped, rebound cholinergic activity
Serotonergic	Brain zaps, anxiety, agitation, insomnia	Same mechanism as SSRIs — serotonin reuptake effect withdraws
Noradrenergic	Anxiety, restlessness, tremor	Norepinephrine system readjusts
Psychological	Mania/hypomania (rare), panic, vivid dreams	Multi-system destabilisation

Imipramine specifically was associated with high severity of withdrawal symptoms in the Henssler 2024 meta-analysis. SRC

The cholinergic rebound is probably the best-understood withdrawal mechanism in this class. TCAs are potent anticholinergics — they block muscarinic acetylcholine receptors. Over time, the brain upregulates these receptors. When the TCA is removed, the now-oversensitive cholinergic system fires excessively, producing the distinctive flu-like GI symptoms that characterise TCA withdrawal. This is a well-documented, physiologically straightforward mechanism.

MAOI Withdrawal DANGEROUS

▼

MAOIs irreversibly inhibit monoamine oxidase enzymes (MAO-A and MAO-B), increasing levels of serotonin, norepinephrine, and dopamine. Withdrawal can produce:

Severe anxiety, agitation, cognitive impairment, pressured speech, psychosis, delirium, paranoid delusions, hallucinations, and catatonia. These have been reported since the 1960s. SRC

MAOI withdrawal is rarer in clinical practice because MAOIs are now rarely prescribed. But the mechanism is notable: the body must regenerate entirely new MAO enzymes (which takes ~2 weeks after stopping irreversible MAOIs). During this period, the monoamine system is profoundly disrupted. This is less a "receptor adaptation" withdrawal and more a "waiting for new enzyme synthesis" withdrawal.

Benzodiazepines

Diazepam (Valium), Alprazolam (Xanax), Lorazepam (Ativan), Clonazepam (Klonopin/Rivotril), Oxazepam, Temazepam, etc.

Withdrawal Symptoms MEDICALLY DANGEROUS

▼

Benzodiazepine withdrawal is one of the few psychiatric drug withdrawals that can be directly life-threatening (along with alcohol and barbiturate withdrawal). Seizures can occur and can be fatal.

Phase	Symptoms	Timeline
Acute	Anxiety, insomnia, tremor, sweating, palpitations, nausea, headache, muscle tension/pain, irritability, difficulty concentrating	1–4 days (short-acting) or 3–7 days (long-acting)
Severe acute	Seizures (grand mal possible), psychosis, delirium, hallucinations (visual/auditory), depersonalisation, sensory hypersensitivity (light, sound, touch)	Within first 1–2 weeks
Protracted	Persistent anxiety, insomnia, tinnitus, pins & needles, burning skin, depersonalisation, cognitive impairment ("clouded thinking"), muscle tension, shaking, subjective sensations of bodily distortion	Months to years

SRC

Medical emergency risk: Abrupt benzodiazepine withdrawal can cause seizures (including status epilepticus) and death. This is not hypothetical — it is documented. Never stop benzodiazepines abruptly without medical supervision.

What Causes Benzo Withdrawal? MECHANISM

▼

This is the best-studied withdrawal mechanism of any psychiatric drug class, though it is still not fully understood.

GABA/Glutamate Imbalance Model

1GABA enhancement: Benzos bind between the α and γ subunits of the GABA-A receptor, increasing the frequency of chloride channel opening → more inhibition → calm, sedation, anti-seizure

2Neuroadaptation: With chronic use, the brain downregulates GABA-A receptors (fewer receptors on the cell surface), alters receptor subunit composition to less sensitive subtypes (chromosome 15 genes upregulated, chromosome 5 genes downregulated), and the GABA-benzodiazepine binding sites become "uncoupled" — the link between them becomes dysfunctional

3Glutamate upregulation: Simultaneously, the excitatory glutamate system compensates via upregulation of AMPA and NMDA receptors. This is possibly MORE important than GABA changes for tolerance and withdrawal

4Drug removed: With reduced GABA function AND enhanced glutamate activity, the brain is in a state of excitotoxic overactivity. The balance has tipped dramatically toward excitation → seizures, anxiety, sensory hypersensitivity, all withdrawal symptoms

SRC

Key insight from research: AMPA (not NMDA) receptor antagonists administered during the "refractory period" of withdrawal can abolish the development of the withdrawal syndrome in animal studies — demonstrating the causal involvement of excitatory glutamate plasticity. NMDA antagonists during chronic benzo administration can actually prevent tolerance from developing. This suggests the glutamate system may be the primary driver, not GABA downregulation alone. SRC

Fluoroquinolone danger: Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin, etc.) are GABA antagonists and competitively displace benzos from their binding sites. They can precipitate acute withdrawal in benzo-dependent individuals and should be contraindicated in anyone on or withdrawing from benzodiazepines. SRC

Symptom-by-Symptom: What Helps & What Hurts DETAILED

▼

Symptom	Proposed Cause	What Helps 📖	What Helps Forums	⚠ Can Worsen
Anxiety / Panic / Rapid Heart Rate	GABA-A receptor downregulation + glutamate upregulation → excitatory dominance	Slow taper (Ashton Manual protocol); Propranolol (taken PRN/intermittently to block physical adrenaline. Avoid daily use to prevent beta-blocker dependence).	Magnesium glycinate (calms glutamate); L-theanine; passionflower; valerian; deep breathing/vagal activation; cold exposure (face in cold water); weighted blankets	Caffeine (directly antagonises GABA); alcohol (temporarily helps then rebounds worse); fluoroquinolone antibiotics; NSAIDs (mild GABA antagonism)
Insomnia / Severe Nightmares	GABA suppression removes sedation; glutamate hyperexcitability keeps brain "wired"; cortisol dysregulation	Sleep restriction therapy (CBT-I); melatonin (low dose); Prazosin (PRN for severe trauma-like nightmares. Avoid daily use to prevent alpha-blocker dependence).	Magnesium glycinate; glycine powder (3g before bed); tart cherry juice; chamomile; Epsom salt baths; consistent wake time	Antihistamines (diphenhydramine etc — anticholinergic, rebound); Z-drugs (same receptor system — contraindicated); alcohol; screen light
Sensory hypersensitivity (light, sound, touch)	Loss of GABAergic inhibitory filtering → sensory input not dampened → hyperexcitability in sensory cortex	No specific pharmacological treatment; time; environmental modification	Sunglasses indoors; earplugs/noise-cancelling headphones; soft fabrics; reducing sensory input deliberately; dark quiet rooms during waves; magnesium; agmatine (emerging)	Loud environments; fluorescent lighting; strong smells; MCAS overlap: histamine can amplify sensory sensitivity — H1 antihistamines may help
Muscle tension / Pain / Twitching	Loss of muscle relaxant effect (benzos are direct muscle relaxants via GABA-A); glutamate hyperexcitability at motor neurons	Magnesium supplementation (physiological basis — muscle relaxation); gentle stretching; physiotherapy	Magnesium (glycinate or malate); Epsom salt baths; gentle yoga; foam rolling; heat packs; topical magnesium oil; turmeric/curcumin (anti-inflammatory)	Intense exercise during acute phase (can trigger symptom waves); fluoroquinolones (tendon damage + GABA antagonism); NSAIDs long-term
Tinnitus	Auditory cortex hyperexcitability from loss of GABAergic inhibition; possibly cochlear GABA receptor changes	No proven treatment; white noise masking; CBT for tinnitus (habituation)	White/pink noise machines; magnesium; NAC (N-acetyl cysteine); acceptance/habituation techniques; avoiding silence	Aspirin/high-dose NSAIDs (ototoxic); loud noise exposure; caffeine (can worsen); stress amplifies perception
Burning skin / Pins & needles	Peripheral and central sensitisation; loss of GABAergic pain modulation; possible small fibre neuropathy; neuroinflammation	No specific proven treatment for benzo-withdrawal neuropathic symptoms; gabapentinoids sometimes tried (but create new dependency)	Magnesium; B12/B-complex; alpha-lipoic acid; topical lidocaine patches; cool compresses; gentle movement; omega-3; low-histamine diet if MCAS suspected	MCAS: Burning/flushing is a hallmark MCAS symptom — try H1+H2 antihistamines + quercetin; touching/massaging the area can worsen allodynia; hot temperatures can increase burning
Depersonalisation / Cognitive fog	Prefrontal cortex + default mode network disruption; dissociative protective response to neurological overload	No specific pharmacological treatment; time; grounding techniques	Lions mane mushroom (some forum reports of cognitive benefit); omega-3 DHA; physical exercise; routine and structure; social interaction; agmatine	Cannabis (strongly worsens DPDR); alcohol; isolation; excessive screen time; Sensitised CNS: often the last symptom to resolve
GI symptoms ("Benzo belly")	Enteric nervous system GABA receptors disrupted; possible mast cell degranulation in gut; stress response	Bland diet; probiotics (limited evidence); time	Low-FODMAP diet; probiotics; bone broth; ginger; peppermint oil capsules; L-glutamine; if MCAS: low-histamine diet + DAO enzyme supplements + famotidine	MCAS: High-histamine foods (fermented foods, aged cheese, alcohol) can massively worsen GI symptoms
Seizures	Glutamate excitotoxicity overwhelming depleted GABA inhibition → uncontrolled neuronal firing	MEDICAL EMERGENCY. Do not attempt self-treatment. Reinstatement of benzodiazepine or anticonvulsant (hospital setting).	N/A — this requires medical intervention, not supplements.	Cold turkey from high-dose/long-term benzos is the primary cause. Fluoroquinolone antibiotics can precipitate seizures. Tramadol lowers seizure threshold.

Agmatine: A Promising NMDA Angle RESEARCH TO WATCH

▼

Given that NMDA/AMPA receptor upregulation is a primary driver of benzo withdrawal (as described above), agmatine — a natural NMDA receptor antagonist derived from the amino acid arginine — has attracted research interest.

The study: Rafi, Rafiq & Farhan (2021) in Beni-Suef University Journal of Basic and Applied Sciences specifically tested agmatine in diazepam-withdrawn rats. After 21 days of diazepam followed by abrupt cessation, agmatine (100mg/kg) administered during the 7-day withdrawal period significantly reduced anxiety, withdrawal symptom scores, and compulsive behaviors, while increasing GABA levels and decreasing glutamate levels — exactly the rebalancing the withdrawal model predicts should help.

Agmatine has also shown anti-withdrawal effects in animal studies for morphine, nicotine, ethanol, cocaine, methamphetamine, and cannabinoid withdrawal — suggesting broad applicability via the glutamate/NMDA mechanism. SRC

Critical caveats: Animal study only. No human clinical trials exist for agmatine in benzodiazepine withdrawal. The mechanism is consistent with what we know about benzo withdrawal, which is why it's interesting — but "mechanistically plausible" does not mean "proven to work in humans."

Z-Drugs

Zolpidem (Ambien/Stilnox), Zopiclone (Imovane), Eszopiclone (Lunesta)

Symptoms & Mechanism BENZO-LIKE

▼

Z-drugs act on the same GABA-A receptor as benzodiazepines — specifically, they are selective for the α1 subunit (which mediates sedation). Despite being marketed as "non-benzodiazepine" sleep aids, withdrawal symptoms are pharmacologically similar to benzo withdrawal:

Symptoms: Rebound insomnia (often severe and worse than pre-treatment), anxiety, tremor, sweating, palpitations, irritability, confusion, and in rare cases seizures (particularly zolpidem at high doses). SRC

Plain English: The whole "Z-drugs aren't benzos" marketing was about patent money, not pharmacology. They hit the same receptor system. They produce the same dependence. They produce the same withdrawal. The Maudsley Guidelines now treat them interchangeably with benzodiazepines for withdrawal management purposes.

Antipsychotics

Quetiapine (Seroquel), Olanzapine (Zyprexa), Risperidone (Risperdal), Aripiprazole (Abilify), Haloperidol, Chlorpromazine, Clozapine, etc.

Withdrawal Symptoms COMPLEX

▼

Chouinard & Chouinard (2017) described three antipsychotic withdrawal syndromes:

Syndrome	Symptoms	Mechanism
Cholinergic rebound	Nausea, vomiting, diarrhoea, sweating, insomnia, anxiety, restlessness, agitation	Antipsychotics (especially olanzapine, clozapine, quetiapine) block muscarinic receptors → withdrawal produces cholinergic rebound
Dopaminergic rebound	Psychosis (often worse than pre-drug), dyskinesia, akathisia, mania	D2 receptor upregulation → dopamine supersensitivity
Withdrawal dyskinesia	Involuntary movements (mouth, face, limbs) appearing shortly after stopping	Nigrostriatal dopamine supersensitivity → considered a subtype of tardive dyskinesia

SRC

Dopamine Supersensitivity Psychosis (DSP) IATROGENIC

▼

This is the most concerning antipsychotic withdrawal phenomenon. Dopamine Supersensitivity Psychosis refers to psychosis caused (or worsened) by the antipsychotic itself, via D2 receptor upregulation. SRC

How Antipsychotics Can Cause Psychosis

1D2 blockade: Antipsychotics block dopamine D2 receptors in the striatum

2Compensatory upregulation: The brain increases the number of D2 receptors and shifts them into a high-affinity state (D2-HIGH) to compensate for the blockade

3Supersensitivity develops: The dopamine system is now hyper-responsive to any dopamine stimulation — even normal endogenous levels

4Drug reduced or stopped: With the blockade removed (or inadequate), the supersensitive receptors are flooded with normal dopamine → rebound psychosis that can be worse than the original illness

SRC

Prevalence estimates: supersensitivity psychosis occurs in approximately 30% of schizophrenia patients and up to 70% of treatment-resistant schizophrenia. SRC

The vicious cycle: DSP creates a devastating trap. Reducing the antipsychotic worsens psychosis → doctor increases the dose → temporary improvement → further D2 upregulation → even more dependence on the drug. This is the pharmacological equivalent of putting out fire with gasoline.

Symptom-by-Symptom: What Helps & What Hurts DETAILED

▼

Symptom	Proposed Cause	What Helps 📖	What Helps Forums	⚠ Can Worsen
Rebound psychosis	Dopamine D2 receptor supersensitivity	Medical management required. Very slow taper (10% reductions, months between steps); Maudsley-style hyperbolic taper.	Very slow taper is everything; peer communities report that "holding" at each dose for extended periods reduces psychotic breakthrough; stress reduction critical	Rapid taper or cold turkey (extremely dangerous); switching to aripiprazole too fast; stimulants; high stress
Akathisia	Dopaminergic disruption	Propranolol (beta-blocker strongly indicated for akathisia); slower taper	Walking/pacing; magnesium; weighted blankets; cold water immersion	Caffeine worsens it. Increasing the antipsychotic dose can worsen it in the long run.
Withdrawal dyskinesia (involuntary movements)	Nigrostriatal dopamine supersensitivity	Reinstatement at lower dose if severe; very slow taper; usually resolves spontaneously in weeks-months	Time; magnesium; B6 (high dose B6 has some evidence for TD generally); omega-3	Increasing the antipsychotic dose (temporarily suppresses but worsens long-term); dopamine agonists
Insomnia (rebound)	Loss of H1 antihistamine effect; loss of 5-HT2A blockade	Melatonin; CBT-I; time	Magnesium; glycine; tart cherry juice; diphenhydramine SHORT-TERM only (replaces lost histamine blockade, but creates own dependency)	Z-drugs/benzos (creates cross-dependency); alcohol; Sensitised CNS: can be severe and long-lasting

Quetiapine (Seroquel) — The "Sleep Med" That Isn't WIDESPREAD

▼

Quetiapine is massively overprescribed off-label as a sleep aid at low doses (25–100mg). At these doses it primarily acts as a histamine H1 antagonist (sedating) and 5-HT2A antagonist, with minimal D2 blockade. However:

Withdrawal still occurs: Insomnia (rebound, often severe), anxiety, nausea, sweating, irritability, and psychotic symptoms have been reported even from low-dose quetiapine discontinuation. The histaminergic and serotonergic withdrawal components are significant even without heavy D2 involvement. SRC

Plain English: If a doctor hands you quetiapine "just as a sleep aid" — you're still being put on an antipsychotic with a withdrawal profile. This is probably the most under-informed prescribing situation in current psychiatry.

Gabapentinoids

Pregabalin (Lyrica), Gabapentin (Neurontin)

Withdrawal Symptoms UNDERRECOGNISED

▼

Symptoms: Anxiety, insomnia, restlessness, palpitations, sweating, headache, tremor, nausea, diarrhoea, loss of appetite, confusion, agitation, disorientation. In severe cases: seizures, delirium, psychosis (including visual and auditory hallucinations), paranoia, suicidal ideation. SRC

In 2025, the FDA updated gabapentinoid labels to include new warnings about suicidal ideation during or after stopping treatment, and withdrawal symptoms including seizures. SRC

Key finding: Withdrawal can occur even from regular (non-abused) doses in patients without psychiatric disorders. Ishikawa et al. (2021) documented three cases of withdrawal from regular prescribed doses (150–600mg/day) — all developed insomnia and anxiety. The literature had previously focused almost exclusively on abuse/dependence cases. SRC

Lithium

Lithium carbonate / lithium citrate — mood stabiliser for bipolar disorder

Withdrawal Symptoms & Rebound Mania HIGH RELAPSE RISK

▼

Lithium withdrawal is unusual compared to other psychiatric drugs. Classic "withdrawal symptoms" (the kind you'd get from stopping a benzo or SSRI) are relatively mild or absent. The main risks are:

Rebound mania/hypomania: Rapid lithium discontinuation (1–7 days) carried a 47% risk of early return of affective illness in one analysis. 50% of mood episodes post-discontinuation occurred within the first 10 weeks. SRC

Debate: Whether rebound mania represents true "withdrawal" or simply the return of the underlying illness once treatment stops is genuinely debated. Schou (1993) examined the evidence and expressed scepticism about a specific "lithium withdrawal syndrome." The practical implication is the same either way: taper very slowly (3–6 months recommended) and do so under medical supervision.

First-Generation Antihistamines

Diphenhydramine (Benadryl), Promethazine (Phenergan), Doxylamine (Unisom)

Withdrawal Symptoms & The Sleep Trap O.T.C. TRAP

▼

First-generation antihistamines cross the blood-brain barrier and block both H1 (histamine) and muscarinic (acetylcholine) receptors. Because they are available over-the-counter, they are frequently abused or heavily relied upon during psychiatric withdrawal to force sleep.

What Happens When You Stop

1Histamine Rebound: The brain upregulates histamine receptors. Stopping the drug causes a massive flood of histamine activity resulting in severe rebound insomnia, profound anxiety, racing thoughts, and intense, unscratchable itching (pruritus).

2Cholinergic Rebound: Because these drugs are also strong anticholinergics, stopping them triggers a cholinergic rebound similar to TCA withdrawal: nausea, sweating, diarrhea, and stomach cramps.

The Danger: Taking Benadryl or Doxylamine long-term to survive Benzo or SSRI insomnia creates a potent secondary dependency. Furthermore, their anticholinergic load has been strongly linked to long-term cognitive decline and dementia risk in older adults.

Adrenergic Drugs (Beta & Alpha Blockers)

These are primarily blood pressure or heart medications, but they are frequently used off-label to survive psychiatric withdrawal. Because they alter the central nervous system, they come with their own withdrawal traps.

Propranolol & Beta-Blockers: The Adrenaline Trap REBOUND RISK

▼

Propranolol (along with Metoprolol and Atenolol) is a beta-blocker that stops adrenaline and noradrenaline from binding to beta receptors. Propranolol specifically crosses the blood-brain barrier. It is incredibly effective at stopping the physical panic, high heart rate, sweating, tremors, and akathisia caused by SSRI or Benzo withdrawal.

The Beta-Receptor Upregulation Trap

1Blockade: Propranolol blocks the beta receptors, preventing the physical sensation of panic.

2Adaptation: The body senses it is not getting enough adrenaline signals, so it creates *more* beta receptors and makes the existing ones hypersensitive to compensate.

3The Rebound: If you stop taking the beta-blocker abruptly after daily use, normal amounts of adrenaline suddenly hit a massive surplus of hypersensitive receptors.

SRC

Beta-Blocker Withdrawal Symptoms
Severe rebound tachycardia (racing heart), blood pressure spikes, profound anxiety/panic, sweating, tremors, palpitations, and in severe cases (especially for those with underlying cardiac issues) angina or myocardial infarction.

The Solution (Intermittent/PRN Use): The fastest way to avoid this trap is to not take beta-blockers daily. Using them *PRN* (as needed) for severe waves of akathisia or panic prevents the body from downregulating the receptors.

Timeline: If you *have* taken them daily and need to stop, they must be tapered over 1-4 weeks. The rebound syndrome typically peaks 24-72 hours after the last dose and resolves within 1-2 weeks. It is acute and dangerous, but much shorter than psychiatric PAWS.

Prazosin (Minipress) & Alpha-Blockers: The Nightmare Trap SECONDARY DEPENDENCY

▼

Prazosin is an alpha-1 adrenergic blocker originally designed for high blood pressure. It is now widely prescribed off-label by psychiatrists to treat PTSD and the severe, trauma-like nightmares often triggered by psychiatric withdrawal. SRC

It works by blocking norepinephrine in the brain specifically during sleep, stopping the "fight or flight" response from hijacking your dreams. However, just like with beta-blockers, chronic daily use causes the alpha-1 receptors to become hypersensitive.

Prazosin Withdrawal Symptoms
Severe rebound insomnia, sudden return of intense nightmares, nocturnal panic attacks, and rebound hypertension (sudden high blood pressure).

Management & PRN Use: Like propranolol, taking Prazosin intermittently (PRN) rather than every single night reduces the risk of receptor upregulation. If it has been taken daily for an extended period, it must be tapered slowly. The biggest risk when *starting* Prazosin is "first-dose syncope" (fainting when standing up due to a sudden drop in blood pressure), which is why it is usually taken strictly at bedtime.

MCAS & Central Nervous System Sensitisation

Why some people react to everything during withdrawal — and why supplements that help most people can make things worse for them.

What Is MCAS and Why Does It Show Up in Withdrawal? EMERGING

▼

Mast Cell Activation Syndrome (MCAS) is an immune condition where mast cells (a type of immune cell) inappropriately release chemical mediators — histamine, cytokines, prostaglandins — in response to stimuli that shouldn't trigger them. Estimated prevalence: 5–10% of the general population, predominantly in Caucasian females. SRC

The benzo-MCAS connection is real and documented:

Why benzos mask MCAS — and withdrawal unmasks it

1Benzodiazepines stabilise mast cells. They directly interact with mast cells and reduce chemical mediator release. This is documented in clinical practice — benzos are prescribed as last-resort MCAS treatment when antihistamines fail.

2While on benzos, MCAS symptoms are suppressed. The person may never know they have MCAS because the drug is treating it.

3During withdrawal, mast cells are unleashed. The stabilising effect is removed AND the nervous system is in a hyperexcitable state (glutamate upregulation) — mast cells respond to stress/excitotoxicity signals by degranulating.

4Result: Symptoms appear that look like allergies, food intolerances, "benzo flu," "benzo belly," burning skin, flushing, hives — all potentially mast cell-mediated.

SRC

Hard data (2025 preprint): A medRxiv preprint (2025/2026) analysing 39 patients in a specialty benzo taper program found that 54% met criteria for MCAS-overlap (defined as ≥2 of 21 mast cell-related symptoms rated ≥5/10 severity). MCAS-overlap was present in 100% of patients with an Autonomic withdrawal phenotype and 69% of those with an Excitatory-Neuroinflammatory phenotype. This is the first study to formally map MCAS onto benzo withdrawal phenotypes. SRC

Central Sensitisation: The "React to Everything" State KEY CONCEPT

▼

Central sensitisation (CS) occurs when the central nervous system gets locked into a state of hyperreactivity. Neurons fire more easily, sensory input is amplified, pain thresholds drop, and the brain becomes hypersensitive to stimuli that would normally be sub-threshold. It involves ion channel upregulation, reduced inhibitory control, and maladaptive neural plasticity. SRC

In psychiatric drug withdrawal, CS explains why:

The Sensitised Withdrawal State

→Supplements that help most people can make YOU worse. In a sensitised nervous system, any neuroactive substance — even "calming" ones like magnesium, L-theanine, or valerian — can trigger paradoxical reactions. The CNS is so hyperexcitable that even small chemical inputs create outsized responses.

→New food sensitivities appear. Foods you ate your whole life suddenly cause reactions. This may involve both MCAS (mast cell degranulation in gut) and central sensitisation (amplified sensory processing of GI signals).

→Sound, light, touch become painful. Allodynia (pain from normally non-painful stimuli) and hyperacusis (sound sensitivity) are hallmarks of central sensitisation.

→"Windows and waves" pattern. Peer communities widely describe alternating periods of feeling better ("windows") and feeling terrible ("waves"). This likely reflects oscillating neuroplasticity as the brain attempts to recalibrate.

What Helps

From the research, from peer support communities, and from hard-won experience. Some of this is evidence-based. Some is observational. I'll tell you which is which.

1. Slow, Hyperbolic Tapering EVIDENCE-BASED

▼

The single most important intervention. The Maudsley Deprescribing Guidelines (Horowitz & Taylor, 2024) recommend hyperbolic tapering — reducing by progressively smaller amounts as the dose gets lower. This accounts for the fact that receptor occupancy does not decrease linearly with dose; it follows a hyperbolic curve. Dropping from 20mg to 10mg of an SSRI is not "cutting in half" — it may reduce receptor occupancy by only ~10%. But dropping from 2mg to 0mg could reduce occupancy by 40–50%. SRC

In practice: Tapers should typically take months, not weeks. The final steps (the last few milligrams or even fractions of milligrams) often take the longest. Liquid formulations, compounding pharmacies, or bead-counting are often necessary because commercial dose forms don't come in small enough increments.

Key principle: The rate of taper should be guided by the patient's symptoms, not a calendar. If symptoms are bad, hold the dose or slow down. If symptoms are manageable, continue. This patient-led approach is advocated by both the Maudsley Guidelines and peer communities.

2. Targeted Prescription Helpers OFF-LABEL

▼

Sometimes, the withdrawal symptoms from one class of drug are so severe that doctors prescribe a different class of drug off-label to survive the taper. While effective, they all carry the risk of creating a secondary dependency.

Medication	What it targets in withdrawal	How it helps & Warnings
Propranolol (Beta-blocker)	Physical panic, high heart rate, tremors, and Akathisia (severe inner restlessness).	Blocks adrenaline physical symptoms. A vital lifeline for akathisia caused by SSRI/Antipsychotic withdrawal. Warning: Use intermittently (PRN) to avoid dependence. Daily use causes beta-receptor upregulation, requiring its own taper to avoid dangerous heart rate/BP spikes.
Prazosin / Minipress (Alpha-blocker)	Severe insomnia and trauma-like nightmares.	Blocks norepinephrine spikes in the brain during sleep. Excellent for withdrawal-induced nightmares. Warning: Can cause sudden fainting (first-dose syncope). Intermittent (PRN) use is safer; daily use creates rebound insomnia and hypertension if stopped abruptly.

3. Supplements & Cannabinoids ANECDOTAL + EXPERIENTIAL

▼

Here's what gets talked about most in peer communities. There are no rigorous clinical trials specifically studying supplements for psychiatric drug withdrawal. The evidence for each is either from adjacent research or from consistent peer reporting.

Supplement	What peers report	Important Notes
NAC (N-Acetyl Cysteine)	Widely reported to clear "brain fog" and reduce obsessive, racing thoughts. Acts as a powerful glutamate modulator and reduces neuroinflammation.	Strong evidence for OCD/excitability. Drives the cystine-glutamate antiporter to clear excess glutamate. (Note: Many peers, including the GTT dataset, report taking 1200mg in the morning with high success and no adverse effects.) Smells like sulfur.
Taurine	Used to calm physical anxiety, lower heart rate, and induce sleep. Modulates intracellular calcium and acts as a mild GABA agonist.	Mixed peer reports. Because it directly tickles the GABA-A receptor, some find it incredibly calming, while highly sensitized individuals report it can trigger withdrawal "waves." Start with a very low dose.
CBD Oil (Cannabidiol)	Widely reported as a lifesaver for balancing the nervous system, reducing muscle tension, and calming immune/MCAS flare-ups.	Low and slow. Not everyone tolerates CBD oil well, especially with a highly sensitized CNS. Start with tiny doses to test your reaction.
THC & CBN	Highly effective for treating severe withdrawal-induced insomnia when standard sleep hygiene fails. CBN is oxidized/aged THC that is significantly more sedating.	See THC wildcard warning below. Must be dosed carefully and always paired with CBD.
Agmatine	An NMDA antagonist derived from arginine. Many users report it completely stops the physical "electricity", nerve tension, and pins-and-needles feelings on the skin.	Usually dosed 1.5g morning and evening. Mechanistically plausible for glutamate excitotoxicity (Benzo/Gabapentinoid withdrawal).
Stabilium (Garum Armoricum)	An ancient Roman deep-water fish extract rich in specific peptides and Omega-3s. Heavily reported to balance deep depression and mood drops without synthetic chemicals.	Often dosed at 3-6 pills daily. Frequently recommended by holistic psychiatrists as a non-chemical SSRI alternative.
Magnesium Glycinate	Calms glutamate excitability, helps sleep, reduces muscle tension.	Ensure it is "Elemental" magnesium.
L-theanine	Calming, takes the edge off anxiety without sedation.	Some evidence for stress reduction generally.

The "Cold Turkey" Trap & Why Basic Supplements Cause Panic:
Why do some people react horribly to simple vitamins, while others find them lifesaving? Peer data and neuroadaptation literature strongly suggest that people who experience "paradoxical reactions" to basic supplements are typically those who cold-turkeyed (CT) or tapered much too fast.

This massive neurochemical shock causes severe excitotoxicity, leaving the Central and Peripheral Nervous Systems highly traumatized and sensitized. When you are depleted of vitamins/minerals, your body desperately needs them, but dropping a massive dose into a sensitized system is like turning a firehose on a parched plant. Always start low and go extremely slow to avoid triggering a reaction.

4. Exercise EVIDENCE-SUPPORTED

▼

Cardiovascular exercise is one of the few interventions with some evidence base that is also consistently reported as helpful by people going through withdrawal. Exercise stimulates nerve cell growth, increases serotonin and norepinephrine activity, releases endorphins and ANP (atrial natriuretic peptide — reduces pain and stress response), and improves sleep. SRC

Caveat from experience: During acute or severe withdrawal, exercise can sometimes worsen symptoms — particularly if the nervous system is in a hypersensitive state (common in benzo and SNRI withdrawal). The advice from peer communities is: do what you can, when you can. Walking is exercise. Don't push through symptom flares just because "exercise helps."

What Doesn't Help (or Makes It Worse) AVOID

▼

The THC Wildcard: While THC helps some people sleep, for many in a highly sensitized withdrawal state, THC is a massive wildcard. It can trigger severe panic attacks, racing thoughts, and profound depersonalization. If used, it should be started incredibly low and generally paired at least 1:1 with CBD to buffer the psychoactive effects.

Adding new psychiatric drugs to treat withdrawal symptoms: This is the most dangerous trap. Doctors frequently prescribe Trazodone, Mirtazapine, or Quetiapine to fix the insomnia caused by SSRI/Benzo withdrawal. This creates polypharmacy, establishes secondary dependencies, and forces you to undergo a completely new withdrawal syndrome later.

Being told it's "relapse": This is the number one complaint from peer communities. Withdrawal symptoms are frequently dismissed by doctors as the return of the original condition, leading to reinstatement at higher doses or addition of new drugs — which can worsen the situation.

Cold turkey: Stopping any psychiatric drug abruptly (especially benzos, which can cause fatal seizures). Even "rapid tapers" over 1–2 weeks are often too fast for long-term users.